Sat.May 25, 2024

article thumbnail

Wide complex tachycardia, resistant to cardioversion. Some fascinating features here.

Dr. Smith's ECG Blog

An elderly dialysis patient presented with chest pain. She has poor LV function. Previous echo 4 months ago (confirmed with ED bedside echo): The estimated left ventricular ejection fraction is 30%. Severely decreased LV function. Regional wall motion abnormality-inferior, inferolateral, septum, anterolateral, anterior and apex, lateral. Here is her ECG: Regular Wide Complex Tachycardia.

article thumbnail

ALIGN Study: Atrasentan Shows Significant Benefit on Proteinuria in IgAN at 36 Weeks

HCPLive

Atrasentan significantly reduces proteinuria in patients with IgA nephropathy, showing a 36.1% reduction compared to placebo at 36 weeks.

115
115
article thumbnail

Access Ends Tonight

Dr. Paddy Barrett

I met a friend of mine from the Middle East a few weeks ago. He has been reading this newsletter for over a year. He said he loves it. He doesn't read every article but reads most of them. He’s busy. We all are. When we were out for dinner, he asked me for the main things he needed to know about preventing heart disease. What causes heart disease?

article thumbnail

SGLT2 Inhibitors Can Improve Anemia in Patients with CKD

HCPLive

Data from ERA 24 builds on previous research examining the effect of SGLT2 inhibitors on hemoglobin levels among patients with chronic kidney disease.

article thumbnail

GLP-1 Agonists in Adolescents and Young Adults; Benefits of Cancer Drug Trials

Med Page Today

(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center.

Cancer 52
article thumbnail

Felzartamab Proves Safety, Potential for Therapeutic Benefit on Antibody-Mediated Rejection Following Kidney Transplant

HCPLive

Hear from Katharina Mayer, MD, and Georg Böhmig, MD, on the results of the phase 2 trial of felzartamab in patients with antibody-mediated rejection following kidney transplantation.

article thumbnail

Patient-reported Symptomatic Events Do Not Adequately Reflect Atrial Arrhythmia

HeartRhythm

Management of atrial fibrillation is frequently geared towards improving symptoms. Yet, the magnitude of symptom rhythm discordance is not well known in the setting of ambulatory electrocardiographic (AECG) monitoring.

More Trending

article thumbnail

Size of Self-Expandable Transcatheter Heart Valve and Mid-Term Adverse Events After Transcatheter Aortic Valve Replacement

The American Journal of Cardiology

Publication date: Available online 24 May 2024 Source: The American Journal of Cardiology Author(s): Hirofumi Hioki, Masanori Yamamoto, Yusuke Watanabe, Yohei Ohno, Fumiaki Yashima, Toru Naganuma, Norio Tada, Shinichi Shirai, Futoshi Yamanaka, Kazuki Mizutani, Masahiko Noguchi, Masaki Izumo, Kensuke Takagi, Masahiko Asami, Hiroshi Ueno, Hidetaka Nishina, Toshiaki Otsuka, Kentaro Hayashida, OCEAN-TAVI Investigators

article thumbnail

Antinephrin Autoantibodies Could Aid in Predicting Disease Activity in Nephrotic Syndrome

HCPLive

Circulating antinephrin autoantibodies identified as reliable biomarkers for MCD and primary FSGS, enhancing diagnostic precision and monitoring of nephrotic syndromes.

article thumbnail

Quality of Life in Older Adults with Stable Ischemic Heart Disease and Diabetes Mellitus: A Post-hoc Analysis of the BARI 2D Trial

The American Journal of Cardiology

Publication date: Available online 24 May 2024 Source: The American Journal of Cardiology Author(s): Dae Yong Park, Yasser Jamil, Mohamad B. Moumneh, Wayne Batchelor, Michael G. Nanna, Abdulla A.